Background. The World Health Organization, African Region, set the goal of achieving measles elimination by 2020. Namibia was one of seven African countries to implement an accelerated measles control strategy beginning in 1996. Following implementation of this strategy, measles incidence decreased; however, between 2009 and 2011 a major outbreak occurred in Namibia. Methods. Measles vaccination coverage data were analysed and a descriptive epidemiological analysis of the measles outbreak was conducted using measles case-based surveillance and laboratory data. Results. During 1989 -2008 (the first routine dose of measles vaccine) coverage increased from 56% to 73% and five supplementary immunisation activities were implemented. During the outbreak (August 2009 -February 2011), 4 605 suspected measles cases were reported; of these, 3 256 were confirmed by laboratory testing or epidemiological linkage. Opuwo, a largely rural district in north-western Namibia with nomadic populations, had the highest confirmed measles incidence (16 427 cases per million). Infants aged ≤11 months had the highest cumulative age-specific incidence (9 252 cases per million) and comprised 22% of all confirmed cases; however, cases occurred across a wide age range, including adults aged ≥30 years. Among confirmed cases, 85% were unvaccinated or had unknown vaccination history. The predominantly detected measles virus genotype was B3, circulating in concurrent outbreaks in southern Africa, and B2, previously detected in Angola. Conclusion. A large-scale measles outbreak with sustained transmission over 18 months occurred in Namibia, probably caused by importation. The wide age distribution of cases indicated measles-susceptible individuals accumulated over several decades prior to the start of the outbreak.
RESEARCH
Measles is one of the most contagious viral diseases known and can cause severe disease and death. Measles is vaccine preventable with a safe, effective and inexpensive vaccine that has been avail able since 1963. The World Health Organization (WHO) currently recommends two doses of measles-containing vaccine (MCV) for all children. In Africa, routine measles vaccination for infants started in the 1980s through the Expanded Program on Immunization. Subsequently, accelerated measles control using both routine vaccination and mass campaigns started in the 1990s. Estimated measles deaths in Africa decreased by 85% from 337 000 in 2000 to 50 000 in 2010, [1] and in 2011, the goal of regional measles elimination by 2020 was set. [2] Namibia, which gained independence from South Africa (SA) in 1990, had an estimated population of 2.1 million in 2009 [3] (an annual growth rate of 2.6% was used to project a 2009 population) and a population density of 2.1 persons per square kilometre, the second-lowest population density in the world. The country is divided administratively into 34 health districts in 13 regions, including those with the highest populations in the northern part of the country along the border with Angola, and in the central and southern parts of the country. More than 67% of Namibian residents are rural dwellers. [4] Routine measles vaccination began in Namibia in 1983, and the childhood routine immunisation schedule has included one dose of measles vaccine given to infants aged 9 months. In 1996, Namibia implemented an accelerated measles control strategy that included periodic mass vaccination campaigns. Despite these efforts, a large measles outbreak occurred during 2009 -2011, affecting all areas of the country and people of all ages. To better understand the evolution of this outbreak and provide guidance for future measles elimination efforts, a study was conducted to describe the measles vaccination coverage through routine immunisation and supplementary immunisation activities (SIAs), and the measles epidemiology of the 2009 -2011 outbreak.
Methods

Routine immunisation and SIAs
From 1996 to 2011, the first dose of measles-containing vaccine (MCV1) was administered at age 9 months. Additional doses of MCV were given to infants and children during periodic SIAs. In addition to the administrative MCV1 coverage data reported by the Ministry of Health and Social Services, we analysed coverage estimates for MCV1 provided by WHO/United Nations Children's Fund (UNICEF) for children aged 1 year. [5] We calculated SIA administrative coverage by 
Measles surveillance
We analysed annual measles cases reported using data from the WHO/UNICEF Joint Reporting Form from 1987 to 2011 and from national measles case-based surveillance data reported to the WHO from 2009 to 2011. [5] Case-based surveillance with laboratory testing for all suspected measles cases was introduced by the WHO Africa Regional Office in 1999. [6, 7] For case-based measles surveillance, the clinical case definition for suspected measles cases was an illness characterised by maculopapular rash, fever and one or more of conjunctivitis, coryza, and cough, or any illness in a patient in which the clinician suspected measles. [8] Investigations of suspected cases included collection of demographic and clinical information (i.e. age, sex, address, vaccination history and date of rash onset) and collection of a serum or urine specimen for laboratory testing. Suspected measles cases were subsequently classified as laboratory-confirmed, epidemiologically linked, clinically compati ble or discarded, using the standard WHO algorithm. A suspected measles case was classified as laboratory confirmed if the casepatient had a positive measles-specific IgM antibody test and had not received measles vaccination during the 30 days before rash onset. An epidemiologically linked case was defined as one meeting the suspected measles case definition and having contact (i.e. lived in the same district or adjacent districts with plausibility of transmission) with a laboratory-confirmed measles case with rash onset during the preceding 30 days. Suspected measles cases were considered confirmed either by laboratory testing or epidemiological link. Any cases that were reported in Namibia with a date of rash onset between 2 August 2009 (epidemiological week (epi-week) 31, 2009) and 2 February 2011 (epi-week 5, 2011) were considered part of this outbreak. Incidence rates were calculated by dividing the total number of confirmed cases reported from each district by the district population and multiplying by 1 000 000. Data were analysed using Excel (Microsoft Corporation, USA) and SAS version 9.3 (SAS Institute, USA).
Laboratory diagnostics
Testing for measles-specific IgM antibody (anti-measles IgM) was performed at Namibia Institute of Pathology or the National Institute for Communicable Diseases (NICD), SA, using a standard ELISA (Enzygnost for IgM, Dade Behring, Germany). To identify circulating measles virus genotypes, molecular diagnostic testing was performed at NICD. RNA was extracted from available specimens (serum or throat swab) using the QIAamp viral RNA mini-kit (QIAGEN, Germany), and amplified by reverse transcriptase-polymerase chain reaction (RT-PCR) using primers MeV214 and MeV216, designed to target a 634-nucleotide region coding for the 3´ terminus of the nucleoprotein (N) gene (measles genotyping kit v2.0, Centers for Disease Control, USA). Amplicons were sequ enced using standard protocols (BigDye Terminator v3.1 cycle sequencing kit, Applied Biosystems, USA). Measles virus genotypes were determined by phylogenetic analyses relative to the WHO measles reference strains using MEGA version 5. [9] 
Results
Routine immunisation and SIAs
The WHO and UNICEF estimates of coverage with MCV1 ranged from 58 to 77% between 1991 and 2011 ( Fig. 1) . [5] Five SIAs were implemented in Namibia before the 2009_31  2009_33  2009_35  2009_37  2009_39  2009_41  2009_43  2009_45  2009_47  2009_49  2009_51  2010_01  2010_03  2010_05  2010_07  2010_09  2010_11  2010_13  2010_15  2010_17  2010_19  2010_21  2010_23  2010_25  2010_27  2010_29  2010_31  2010_33  2010_35  2010_37  2010_39  2010_41  2010_43  2010_45  2010_47  2010_49  2010_51 n/a n/a n/a SIA ‡ 9 mo -14 yr [10, 11] The SIA conducted in 2006 was subnational; the other four were nationwide. All SIAs targeted children aged 9 -59 months, with the exception of the 1997 SIA, which targeted children aged 9 months -14 years. Reported administra tive vaccination coverage achieved during these SIAs ranged from 90 to 104%. The 2009 SIA was conducted in June, ~2 months before the measles outbreak began in Namibia. During September -December 2009, an outbreak response immunisation (ORI) SIA was conducted in the six districts most affected by the outbreak at that time (Eenhena, Engela, Okongo, Opuwo, Outapi and Rundu) (Fig. 2) . The ORI SIA was selective and targeted children aged 6 -59 months who had never been vaccinated. However, the outbreak continued and in February 2010 additional ORI activities were conducted in Opuwo district, target ing everyone aged 6 months or older irres pective of previous vaccination status. During February and March 2010, ORI campaigns were conducted in Outapi, Onandjokwe and Rundu districts, targeting children aged 6 -59 months irrespective of previous vaccination status.
Measles epidemiology and outbreak response
During the outbreak (2 August 2009 -2 February 2011), 4 605 suspected measles cases were reported in Namibia. Of these, 462 (10%) were laboratory confirmed, 2 794 (61%) were epidemiologically linked, 70 (2%) were clinically compatible but no speci men was available for testing, and 1 279 (28%) were discarded. Of the 3 256 confirmed cases, most occurred during 2009 (1 846 cases, 56.7%); 1 396 (42.9%) occurred in 2010, and 14 (0.4%) occurred in 2011 (Table 1) . Thirty-two (94%) of 34 districts reported three or more confirmed cases. Only Karasburg district reported no cases during the outbreak. Twenty-seven measlesrelated deaths were reported.
Information on age and sex was available for 3 233 (99%) and 3 256 (100%) of the confirmed cases, respectively. Cases were widely distributed across all ages: 1 215 (38%) cases occurred in infants and children aged <5 years (including 696 (22%) aged ≤11 months), 791 (24%) in children aged 5 -14 years and 1 227 (38%) in persons aged ≥15 years (Table 1 and Fig. 3 ). Infants aged ≤11 months had the highest cumulative incidence during the outbreak (9 252 cases per million), followed by children aged 1 -4 years (2 306 per million) and those aged 5 -14 years (1 468 per million) ( Table 2) . In urban areas, large proportions of confirmed cases were aged ≤11 months or ≥15 years (29% and 47%, respectively) relative to rural areas (19% and 39%, respectively) ( Table 2) .
Vaccination status information was available for 3 059 (95%) of confirmed cases; 1 025 (34%) were unvaccinated and 1 570 (51%) had unknown vaccination history ( Table 1 ). The proportion of cases that had received ≥1 dose of MCV was 15% overall and low among all age groups: 11% in infants, 33% in children aged 1 -4 years, 25% in children aged 5 -14 years, and 3% in those aged ≥15 years. In Windhoek, 92% of confirmed cases were either unvaccinated or had unknown vaccination status, and in Opuwo 81% of confirmed cases were unvaccinated and 13% had unknown status.
Before 2009, reported measles outbreaks in Namibia occurred in 1987, 1992, 1996 -1997 and 2002 -2003 (Fig. 1) . From 2004 to 2008, fewer than 10 measles cases were reported annually. During the first half of 2009, 14 confirmed measles cases were reported; however, beginning in August 2009 (epi-week 31), clusters of cases were reported, primarily in the Engela district in northern Namibia near the border with Angola. Reported cases increased sharply in epi-week 36 and peaked with 252 cases in epi-week 43 (Fig. 2) .
During the first 5 months of the outbreak (epi-weeks 31 -52, 2009), reported measles incidence in three districts along the Angola border was >1 000 per million population 
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( Fig. 4) . Of the three districts, Opuwo had the highest confirmed incidence at 12 390 cases per million population. Opuwo has a high concentration of Ovahimba pastoralist communities, and information collected during field visits and discussions with clinicians at the Opuwo district hospital showed that most cases occurred among Ovahimba communities. Ovahimba are Bantu pastoralists who are nomadic herders of cattle and goats; although they maintain homesteads, they migrate freely throughout Kunene region on the border with Angola to find fresh vegetation to feed their livestock. Between August and December 2009, the incidence in the capital district of Windhoek was 2 500 cases per million, and a total of 22 (65%) districts had a measles incidence of ≥50 cases per million (Fig. 4) . During the first half of 2010 (epi-weeks 1 -26), four districts had measles incidence ≥1 000 cases per million, including Opuwo (3 935 cases per million) (Fig. 4) . Measles incidence increased in most districts during the second half of 2010 (epi-weeks 27 -52), but decreased to zero cases in Opuwo. Between 1 January and 2 February 2011 (end of the outbreak), only Rundu in the north-east of the country had an incidence of ≥50 cases per million population (Fig. 4) . Opuwo had the highest cumulative incidence (16 427 
Laboratory diagnostics
Genotype data were available for a total of 64 specimens from the Namibia outbreak. For August -December 2009, all four specimens from Namibia were measles virus genotype B2. During 2010, 46 (94%) of 49 specimens were genotype B2, and 3 were genotype B3 (6%). In 2011, 1 (9%) of 11 specimens was B2, and 10 (91%) were B3. Genotype B2 was previously detected in Angola and the Democratic Republic of Congo, and B3 was the predominant genotype circulating in the outbreaks in southern Africa that started in SA during 2009 -2010. [10] 
Discussion
Even with accelerated measles control efforts in Namibia beginning in 1997, MCV1 coverage estimates ranged from 59% to 77% between 1991 and 2011. However, with periodic SIAs, annual reported measles incidence decreased to less than one case per million in Namibia by 2008 and transmission of endemic measles virus was probably interrupted. [12] However, during 2009 -2010, Namibia was one of several countries in southern Africa that experienced measles outbreaks following prolonged interepidemic periods. The outbreak in Namibia began in several districts in northern Namibia near the border with Angola; three of these districts reported measles incidence ≥1 000 cases per million, including Opuwo with the highest incidence of the outbreak of 12 390 cases per million. The likely cause of the outbreak was separate importations in 2009 and 2010 of measles virus genotypes B2 and B3. Because of an accumulation of unvaccinated, measlessusceptible indi viduals, these importations resulted in sustained measles virus transmission across multiple districts. The wide age distribution of cases suggests that the accumulation of measles-susceptible individuals occurred over several decades before the outbreak.
Despite modest routine measles immunisation coverage and periodic SIAs, the Namibia outbreak started 2 months after a nationwide measles SIA targeting children aged 9 -59 months was conducted in June 2009 with 104% administrative coverage reported. Of confirmed cases during the outbreak, 22% were aged 9 -59 months. Although most cases had missing or unknown information for vaccination status, our analysis suggested that the outbreak was due primarily to failure to achieve and sustain high two-dose measles vaccination coverage through routine immunisation services and SIAs.
The porous border between Angola and Namibia and persistently low routine measles vaccination coverage in Angola (MCV1 cover age ranged from 41% to 74% bet ween 2000 and 2006, and from 77% to 88% between 2007 and 2009 [13] ) probably contributed To achieve the goal of measles elimination by 2020, additional efforts are needed in Namibia to strengthen routine immunisation services and SIA implementation, to achieve ≥95% two-dose coverage and close immunity gaps among measles-susceptible populations. Routine immunisation services should include outreach to communities that have poor access to routine services. Targeting SIA campaigns to include older ages, similar to the ORI SIA conducted in Opuwo, could improve immunity across a wider age range. Introducing a routine sec ond dose of measles-containing vaccine (MCV2) to the childhood immunisation schedule at age 15 -18 months should be considered. [14, 15] The shift of measles epidemiology towards older age groups in Africa has been well documented. [7] However, follow-up SIAs have not addressed susceptibility among older age groups. SIA target age groups have been limited primarily due to inadequate resources. In April 2012, the Measles & Rubella Initiative launched the 2012 -2020 Global Measles and Rubella Strategic Plan to support rubella with measles elimination efforts. [16] The WHO recommends that the introduction of rubella-containing vaccine should include implementation of a catch-up SIA targeted at children across a wide range of ages using combined measles and rubella vaccine. [17] In addition to contributing to rubella elimin ation, these SIAs would provide a unique opportunity to boost population immunity to measles and contribute to the momentum needed to achieve and sustain measles elimination. For example, when combined measles and rubella vaccine is introduced in Namibia, the initial nationwide catch-up SIA using combined measles and rubella vaccine should have a target age group that includes young adults, to close the 
